The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“0%); however, African American and Hispanic women were notable exceptions, with prevalences 57% and 26% greater, respectively than their male counterparts (Park et al., 2003).”
BackgroundMethodInfluentialExcess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2444 · Cited by 1,488
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Cited by
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Insel, T. R. (2010) · Nature · doi:10.1038/nature09552 · Cited by 1,783
Premature Mortality Among Adults With Schizophrenia in the United States
Olfson, M., Gerhard, T., Huang, C., Crystal, S., & Stroup, T. S. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1737 · Cited by 1,083
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review
Ochoa, S., Usall, J., Cobo, J., Labad, X., & Kulkarni, J. (2012) · Schizophrenia Research and Treatment · doi:10.1155/2012/916198 · Cited by 735
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Nasrallah, H. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 714
Self-citationMetabolic syndrome in people with schizophrenia: a review
DE HERT, M., SCHREURS, V., VANCAMPFORT, D., & VAN WINKEL, R. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00199.x · Cited by 634
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., & Lieberman, J. A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.026 · Cited by 556
Self-citationA Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness
Daumit, G. L., Dickerson, F. B., Wang, N.-Y., Dalcin, A., Jerome, G. J., Anderson, C. A. M., Young, D. R., Frick, K. D., Yu, A., Gennusa, J. V., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214530 · Cited by 523
Severe Mental Illness and Risk of Cardiovascular Disease
Newcomer, J. W., & Hennekens, C. H. (2007) · JAMA · doi:10.1001/jama.298.15.1794 · Cited by 433
The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Na, K.-S., Jung, H.-Y., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 427
Scott, D., & Happell, B. (2011) · Issues in Mental Health Nursing · doi:10.3109/01612840.2011.569846 · Cited by 414
Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
CORRELL, C. U., & CARLSON, H. E. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000220851.94392.30 · Cited by 403
Obesity Among Those with Mental Disorders
Allison, D. B., Newcomer, J. W., Dunn, A. L., Blumenthal, J. A., Fabricatore, A. N., Daumit, G. L., Cope, M. B., Riley, W. T., Vreeland, B., Hibbeln, J. R., et al. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.11.020 · Cited by 394
Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00137 · Cited by 339
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332
Vancampfort, D., Wampers, M., Mitchell, A. J., Correll, C. U., De Herdt, A., Probst, M., & De Hert, M. (2013) · World Psychiatry · doi:10.1002/wps.20069 · Cited by 317
Arnold, S. E., Lucki, I., Brookshire, B. R., Carlson, G. C., Browne, C. A., Kazi, H., Bang, S., Choi, B.-R., Chen, Y., McMullen, M. F., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.011 · Cited by 314
De Hert, M. A., van Winkel, R., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., & Peuskens, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.855 · Cited by 314
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Eichorst, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s005 · Cited by 305
Henderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288
Meyer, J. M., Davis, V. G., Goff, D. C., McEvoy, J. P., Nasrallah, H. A., Davis, S. M., Rosenheck, R. A., Daumit, G. L., Hsiao, J., Swartz, M. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.487 · Cited by 286
Self-citationC-Reactive Protein Levels in Schizophrenia: A Review and Meta-Analysis
Miller, B. J., Culpepper, N., & Rapaport, M. H. (2014) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.micu.020813 · Cited by 267
Bradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 256
Paliperidone for schizophrenia
Dolder, C., Nelson, M., & Deyo, Z. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070261 · Cited by 254
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Correll, C. U., Frederickson, A. M., Kane, J. M., & Manu, P. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.017 · Cited by 252
Auquier, P., Lançon, C., Rouillon, F., Lader, M., & Holmes, C. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1325 · Cited by 249
Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
Flowers, S. A., Evans, S. J., Ward, K. M., McInnis, M. G., & Ellingrod, V. L. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1890 · Cited by 235
Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., Rosenheck, R., Davis, S. M., Hsiao, J. K., Stroup, T. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.006 · Cited by 223
Self-citationBora, E., Akdede, B. B., & Alptekin, K. (2017) · Psychological Medicine · doi:10.1017/s0033291716003366 · Cited by 219
Robinson, D. J., Coons, M., Haensel, H., Vallis, M., & Yale, J.-F. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.031 · Cited by 209
Osborn, D. P., Wright, C. A., Levy, G., King, M. B., Deo, R., & Nazareth, I. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-84 · Cited by 208
Galletly, C. A., Foley, D. L., Waterreus, A., Watts, G. F., Castle, D. J., McGrath, J. J., Mackinnon, A., & Morgan, V. A. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412453089 · Cited by 203
Teff, K. L., Rickels, M. R., Grudziak, J., Fuller, C., Nguyen, H.-L., & Rickels, K. (2013) · Diabetes · doi:10.2337/db13-0430 · Cited by 195
“Aripiprazole tends to cause less weight gain than olanzapine (15) and is often considered metabolically neutral (16–18).”
BackgroundBirkenaes, A. B., Opjordsmoen, S., Brunborg, C., Engh, J. A., Jonsdottir, H., Ringen, P. A., Simonsen, C., Vaskinn, A., Birkeland, K. I., Friis, S., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0614 · Cited by 185
Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Leung, J. Y. T., Barr, A. M., Procyshyn, R. M., Honer, W. G., & Pang, C. C. Y. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.04.003 · Cited by 163
Schizophrenia and physical health problems
Von Hausswolff‐Juhlin, Y., Bjartveit, M., Lindström, E., & Jones, P. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01309.x · Cited by 161
Gardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K. E., Keen, A., O'Brien, C., Onagbesan, O., Fung, C., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715000562 · Cited by 140
“(McEvoy et al. 2005; Bobes et al. 2007).”
BackgroundResultMetabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap
McIntyre, R. S., Rasgon, N. L., Kemp, D. E., Nguyen, H. T., Law, C. W. Y., Taylor, V. H., Woldeyohannes, H. O., Alsuwaidan, M. T., Soczynska, J. K., Kim, B., et al. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0010-0 · Cited by 127
Weight gain and metabolic changes during treatment with antipsychotics and antidepressants
Himmerich, H., Minkwitz, J., & Kirkby, K. (2015) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/1871530315666150623092031 · Cited by 122
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia
Stroup, T. S., Olfson, M., Huang, C., Wall, M. M., Goldberg, T., Devanand, D. P., & Gerhard, T. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0042 · Cited by 112
Self-citationFlowers, S. A., Baxter, N. T., Ward, K. M., Kraal, A. Z., McInnis, M. G., Schmidt, T. M., & Ellingrod, V. L. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2214 · Cited by 100
Smith, S., Yeomans, D., Bushe, C. J. P., Eriksson, C., Harrison, T., Holmes, R., Mynors-Wallis, L., Oatway, H., & Sullivan, G. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.07.002 · Cited by 95
Scigliano, G., & Ronchetti, G. (2013) · CNS Drugs · doi:10.1007/s40263-013-0054-1 · Cited by 92
Cardiovascular aspects of antipsychotics
Raedler, T. J. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833f46c9 · Cited by 89
Beyazyüz, M., Albayrak, Y., Eğilmez, O. B., Albayrak, N., & Beyazyüz, E. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.2.148 · Cited by 83
Ellingrod, V. L., Taylor, S. F., Dalack, G., Grove, T. B., Bly, M. J., Brook, R. D., Zöllner, S. K., & Pop-Busui, R. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182485888 · Cited by 84
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., White, R. F., Honer, W. G., & Barr, A. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00203 · Cited by 79
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
Risk of Treatment-Emergent Diabetes Mellitus in Patients Receiving Antipsychotics
Citrome, L. L., Holt, R. I., Zachry, W. M., Clewell, J. D., Orth, P. A., Karagianis, J. L., & Hoffmann, V. P. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k141 · Cited by 64
Vergara-Rodriguez, P., Vibhakar, S., & Watts, J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.07.004 · Cited by 53
Mortality in schizophrenia: clinical and serological predictors
Dickerson, F., Stallings, C., Origoni, A., Schroeder, J., Khushalani, S., & Yolken, R. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt113 · Cited by 50
Cabassa, L. J., Druss, B., Wang, Y., & Lewis-Fernández, R. (2011) · Implementation Science · doi:10.1186/1748-5908-6-80 · Cited by 50
DNA Methylation in Schizophrenia Subjects: Gender and MTHFR 677C/T Genotype Differences
Burghardt, K. J., Pilsner, J. R., Bly, M. J., & Ellingrod, V. L. (2012) · Epigenomics · doi:10.2217/epi.12.25 · Cited by 49
Alam, A., Chengappa, K. N. R., & Ghinassi, F. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.06.015 · Cited by 48
Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia
Morden, N. E., Lai, Z., Goodrich, D. E., MacKenzie, T., McCarthy, J. F., Austin, K., Welsh, D. E., Bartels, S., & Kilbourne, A. M. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.02.009 · Cited by 44
Metabolic Effects of Antidepressant Treatment
Olguner Eker, O., Ozsoy, S., Eker, B., & Dogan, H. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.12373 · Cited by 44
Clinical Trial of Wellness Training: Health Promotion for Severely Mentally Ill Adults
Chafetz, L., White, M., Collins-Bride, G., Cooper, B. A., & Nickens, J. (2008) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e31817738de · Cited by 41
Metabolic and inflammatory genes in schizophrenia
Chase, K. A., Rosen, C., Gin, H., Bjorkquist, O., Feiner, B., Marvin, R., Conrin, S., & Sharma, R. P. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.007 · Cited by 41
Stroup, T. S., Byerly, M. J., Nasrallah, H. A., Ray, N., Khan, A. Y., Lamberti, J. S., Glick, I. D., Steinbook, R. M., McEvoy, J. P., & Hamer, R. M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.013 · Cited by 39
Self-citationThe prevention of diabetes and cardiovascular disease in people with schizophrenia
Holt, R. I. G. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12443 · Cited by 37
High bone turnover but normal bone mineral density in women suffering from schizophrenia
Bergemann, N., Parzer, P., Mundt, C., & Auler, B. (2008) · Psychological Medicine · doi:10.1017/s003329170800319x · Cited by 37
“As a large percentage of patients with schizophrenia are overweight (McEvoy et al. 2005), this might compensate possible risk factors for osteoporosis in patients with this disease.”
BackgroundTemmingh, H., Claassen, A., van Zyl, S., Carrara, H., Dayakalashe, N. M., Myer, L., & Stein, D. J. (2013) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000036 · Cited by 31
Young, S. J., Praskova, A., Hayward, N., & Patterson, S. (2017) · Health & Social Care in the Community · doi:10.1111/hsc.12349 · Cited by 31
Jerrell, J., McIntyre, R., & Tripathi, A. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.2 · Cited by 31
Andrade, C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12130 · Cited by 18
Heart Rate Variability and Metabolic Syndrome in Hospitalized Patients with Schizophrenia
Lee, K., Park, J., Choi, J., & Park, C. G. (2011) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.2011.41.6.788 · Cited by 15
Daumit, G. L., Evins, A. E., Cather, C., Dalcin, A. T., Dickerson, F. B., Miller, E. R., Appel, L. J., Jerome, G. J., McCann, U., Ford, D. E., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1691 · Cited by 13
New-Onset Transilent Hallucinations Possibly Due To Eszopiclone: A Case Study
Duggal, H. S. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0611e · Cited by 10
Seeman, M. V. (2016) · Journal of Obesity Management · doi:10.14302/issn.2574-450x.jom-16-1039 · Cited by 10
Antipsychotic use in the elderly: what doctors say they do, and what they do
Tiller, J., Ames, D., Brodaty, H., Byrne, G., Chawla, S., Halliday, G., Snowdon, J., Hepworth, G., McArdle, P., & Schweitzer, I. (2008) · Australasian Journal on Ageing · doi:10.1111/j.1741-6612.2008.00308.x · Cited by 8
Metadata
- Authors
- McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 80
- Issue
- 1
- Pages
- 19-32
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2062359581
- Cited by
- 1,140
- References
- 46
- FWCI
- 36.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.